Cargando…

Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation

Detalles Bibliográficos
Autores principales: Qiu, Hangyuan, Sun, Yaxun, Pan, Ziwei, Zhou, Jingjun, Wang, Hongkun, Wang, Xiaochen, Cai, Dongsheng, Fu, Guosheng, Gong, Tingyu, Jiang, Chenyang, Liang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715830/
https://www.ncbi.nlm.nih.gov/pubmed/34965010
http://dx.doi.org/10.1002/ctm2.647
_version_ 1784624206013530112
author Qiu, Hangyuan
Sun, Yaxun
Pan, Ziwei
Zhou, Jingjun
Wang, Hongkun
Wang, Xiaochen
Cai, Dongsheng
Fu, Guosheng
Gong, Tingyu
Jiang, Chenyang
Liang, Ping
author_facet Qiu, Hangyuan
Sun, Yaxun
Pan, Ziwei
Zhou, Jingjun
Wang, Hongkun
Wang, Xiaochen
Cai, Dongsheng
Fu, Guosheng
Gong, Tingyu
Jiang, Chenyang
Liang, Ping
author_sort Qiu, Hangyuan
collection PubMed
description
format Online
Article
Text
id pubmed-8715830
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87158302022-01-06 Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation Qiu, Hangyuan Sun, Yaxun Pan, Ziwei Zhou, Jingjun Wang, Hongkun Wang, Xiaochen Cai, Dongsheng Fu, Guosheng Gong, Tingyu Jiang, Chenyang Liang, Ping Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-12-29 /pmc/articles/PMC8715830/ /pubmed/34965010 http://dx.doi.org/10.1002/ctm2.647 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Qiu, Hangyuan
Sun, Yaxun
Pan, Ziwei
Zhou, Jingjun
Wang, Hongkun
Wang, Xiaochen
Cai, Dongsheng
Fu, Guosheng
Gong, Tingyu
Jiang, Chenyang
Liang, Ping
Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation
title Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation
title_full Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation
title_fullStr Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation
title_full_unstemmed Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation
title_short Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation
title_sort inhibition of hsc70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a mybpc3 mutation
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715830/
https://www.ncbi.nlm.nih.gov/pubmed/34965010
http://dx.doi.org/10.1002/ctm2.647
work_keys_str_mv AT qiuhangyuan inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation
AT sunyaxun inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation
AT panziwei inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation
AT zhoujingjun inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation
AT wanghongkun inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation
AT wangxiaochen inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation
AT caidongsheng inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation
AT fuguosheng inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation
AT gongtingyu inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation
AT jiangchenyang inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation
AT liangping inhibitionofhsc70alleviateshypertrophiccardiomyopathypathologyinhumaninducedpluripotentstemcellderivedcardiomyocyteswithamybpc3mutation